EBNA-1: A protein pivotal to latent infection by Epstein-Barr virus

Reviews in Medical Virology

Volumn 10, Issue 2, 2000, Pages 83-100

  Leight, Elizabeth R ^a   Sugden, Bill ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; TRANSCRIPTION FACTOR; VIRUS VECTOR;

CELL CULTURE; DNA REPLICATION ORIGIN; EPSTEIN BARR VIRUS; LATENT VIRUS INFECTION; METAPHASE CHROMOSOME; NONHUMAN; REPLICON; REVIEW; TRANSACTIVATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; VIRUS LATENCY;

EID: 0034103269     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(200003/04)10:2<83::AID-RMV262>3.0.CO;2-T     Document Type: Review

References (14)

1. Niederman JC, McCollum RW, Henle G, Henle W. Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA 1968; 203: 205-209.
2. Evans AS. The transmission of EB viral infections. In Viral Infections in Oral Medicine, Hooks JJ, Jordan GW (eds). Elsevier North Holland: New York, 1982, 211-225
3. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375-382.
4. Siebert JD, Ambinder RF, Napoli VM, Quintanilla ML, Banks PM, Gulley ML. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus. Hum Pathol 1995; 26: 1191-1195.
5. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A 1994; 91: 9131-9135.
6. Crawford DH, Thomas JA, Janossy G, et al. Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft [letter]. Lancet 1980; 1: 1355-1356.
7. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 1981; 4253-4261.
8. de-The G, Geser A, Day NE, et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 1978; 274: 756-761.
9. Geser A, de TG, Lenoir G, Day NE, Williams EH. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 1982; 29: 397-400.
10. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A 1974; 71: 4737-4741.
11. Robinson J, Smith D, Niederman J. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. ' Nature 1980; 287: 334-335.
12. Qu L, Rowe DT. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992; 66: 3715-3724.
13. Miyashita EM, Yang B, Babcock GJ, Thorley LD. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell [published erratum appears in J Virol 1998; 72(11): 9419]. J Virol 1997; 71: 4882-4891.
14. Adams A. Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 1987; 61: 1743-1746.